TickerFacts.

Dexcom Inc (DXCM): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2010-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$1.16B
Year ended 2025-12-31
$1.40B
Trailing 12 months to 2026-06-30
+28.6%
3-year compound annual growth
+26.0%
5-year compound annual growth
2009-12-31: -$43.46M2010-12-31: -$42.90M2011-12-31: -$41.00M2012-12-31: -$49.10M2013-12-31: -$21.90M2014-12-31: -$13.10M2015-12-31: -$46.30M2016-12-31: -$48.90M2017-12-31: -$26.40M2018-12-31: -$157.20M2019-12-31: $191.00M2020-12-31: $366.60M2021-12-31: $367.80M2022-12-31: $547.10M2023-12-31: $783.70M2024-12-31: $817.70M2025-12-31: $1.16B$1.16B
2009-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31$1.16B+42.3%2026-02-12, From 2025-01-01
2024-12-31$817.70M+4.3%2026-02-12, From 2024-01-01
2023-12-31$783.70M+43.2%2026-02-12, From 2023-01-01
2022-12-31$547.10M+48.7%2025-02-18, From 2022-01-01
2021-12-31$367.80M+0.3%2024-02-08, From 2021-01-01
2020-12-31$366.60M+91.9%2023-02-09, From 2020-01-01
2019-12-31$191.00Mn/m2022-02-14, From 2019-01-01
2018-12-31-$157.20Mn/m2021-02-11, From 2018-01-01
2017-12-31-$26.40Mn/m2020-02-13, From 2017-01-01
2016-12-31-$48.90Mn/m2019-02-21, From 2016-01-01
2015-12-31-$46.30Mn/m2018-02-27, From 2015-01-01
2014-12-31-$13.10Mn/m2017-02-28, From 2014-01-01
2013-12-31-$21.90Mn/m2016-02-23, From 2013-01-01
2012-12-31-$49.10Mn/m2015-02-25, From 2012-01-01
2011-12-31-$41.00Mn/m2014-02-20, From 2011-01-01
2010-12-31-$42.90Mn/c2013-02-21, From 2010-01-01
2009-12-31-$43.46Mn/a2012-02-23, From 2009-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Dexcom Inc (DXCM)2025-12-31$1.16B+42.3%
ResMed Inc (RMD)2026-06-30$2.09B+10.8%
MiniMed Group, Inc. (MMED)2026-04-24-$34.00Mn/m
West Pharmaceutical Services Inc (WST)2025-12-31$756.30M+4.3%
Globus Medical Inc (GMED)2025-12-31$756.66M+80.4%
Insulet Corp (PODD)2025-12-31$564.20M+44.8%
Solventum Corp (SOLV)2025-12-31$2.67B+67.8%
ICU Medical Inc (ICUI)2025-12-31$243.57M-7.2%
Teleflex Inc (TFX)2025-12-31$296.11M+11.7%

Compare DXCM, RMD, MMED, WST side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗